GHTC releases a new policy report which provides an agency-by-agency blueprint for US policymakers to supercharge global health R&D in the wake of the COVID-19 pandemic that has revealed both the sector’s chronic neglect and amazing potential.
Learn moreGHTC released a recent report exploring how COVID-19 is impacting the global health R&D sector. Based on qualitative interviews, it looks at both immediate impacts, including disruptions to research and diversion of funding and expertise, as well as long-term challenges and opportunities that may reshape the sector in the years to come.
Learn moreDrugs for Neglected Diseases initiative (DNDi) is a patient needs-driven, not-for-profit R&D organization that works to deliver new treatments for neglected diseases. It recently launched its 2021-2028 Strategic Plan, a vision for global health R&D for the next decade focused on contributing to a more equitable system for innovation and access.
Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.
Learn More
GHTC submitted testimony for the public record for a hearing held April 16, 2021 by the House Foreign Affairs Subcommittee on International Organizations and Global Corporate Social Impact titled Innovation in Development Policy: Maximizing Impact and Results.
PDF
GHTC joined letters from the Global Health Council Maternal and Child Health Roundtable to House and Senate Appropriators encouraging robust funding for fiscal year 20211 (FY22) for maternal and child heath and nutrition accounts at the US Agency for International Development.
PDF
Health Policy Watch featured a commentary from GHTC Director Jamie Bay Nishi outlining six steps for the US government to pivot from the pandemic to a golden era of global health R&D.
ViewSorry, no events available at this time
", type: "module" %}
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
